E
EVH icon

Ergoteles’s Evolent Health EVH Stock Holding History

Ergoteles’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-13,694
Closed -$492K – 1574
2022
Q3 		$492K Buy
+13,694
New +$482K 0.02% 768
2022
Q1 		– Sell
-11,660
Closed -$323K – 1341
2021
Q4 		$323K Buy
11,660
+2,058
+21% +$59K 0.01% 828
2021
Q3 		$298K Sell
9,602
-1,998
-17% -$48K 0.01% 797
2021
Q2 		$245K Buy
+11,600
New +$232K 0.01% 1174

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

Ergoteles's EVH Position: Q4 2022 in Review

Ergoteles sold out of Evolent Health (EVH) in Q4 2022, closing a stake of 13,694 shares — an estimated $492K sold.

Ergoteles first reported a position in EVH in Q2 2021 and held it in 4 quarters. The position peaked at $492K in Q3 2022. 232 funds tracked by Wall St. Rank hold EVH as of Q4 2022.

  • Ergoteles reported no remaining Evolent Health position as of Q4 2022 after selling out during the quarter.
  • Ergoteles sold 13,694 Evolent Health shares in Q4 2022, an estimated $492K.
  • Ergoteles first reported a position in Evolent Health in Q2 2021 and held it in 4 quarters.
  • Ergoteles's Evolent Health position peaked at $492K in Q3 2022.
  • 232 funds tracked by Wall St. Rank held Evolent Health as of Q4 2022.

Based on Ergoteles's 13F filing for Q4 2022, filed 14 Feb 2023.